Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziv Raviv

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal for Immunotherapy of Cancer|March 12, 2021
Host response to immune checkpoint inhibitors contributes to tumor aggressivenessIrina Khononov, Eyal Jacob, Ella Fremder, et al.
Oncotarget|February 2, 2017
The antiangiogenic role of the pro-inflammatory cytokine interleukin-31Shiri Davidi, Ella Fremder, Tal Kan, et al.
Neoplasia (New York, N.Y.)|June 25, 2014
Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapyErez Hasnis, Dror Alishekevitz, Svetlana Gingis-Veltski, et al.
Scientific Reports|September 1, 2019
Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cellsMadeleine Benguigui, Iris S Weitz, Michael Timaner, et al.
Oncogene|January 16, 2023
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitorsAvital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, et al.
Cancer Research|January 6, 2018
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating CellsMichael Timaner, Nitzan Letko-Khait, Ruslana Kotsofruk, et al.
Frontiers in Immunology|July 25, 2022
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant TumorsMadeleine Benguigui, Avital Vorontsova, Michael Timaner, et al.
Cancers|June 2, 2021
Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung CancerMaryna Bondarenko, Marion Le Grand, Yuval Shaked, et al.
Oncotarget|September 9, 2015
Dequalinium blocks macrophage-induced metastasis following local radiationMichael Timaner, Rotem Bril, Orit Kaidar-Person, et al.
Journal for Immunotherapy of Cancer|June 18, 2021
IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cellsKsenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|March 12, 2021
Host response to immune checkpoint inhibitors contributes to tumor aggressivenessIrina Khononov, Eyal Jacob, Ella Fremder, et al.
Oncotarget|February 2, 2017
The antiangiogenic role of the pro-inflammatory cytokine interleukin-31Shiri Davidi, Ella Fremder, Tal Kan, et al.
Neoplasia (New York, N.Y.)|June 25, 2014
Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapyErez Hasnis, Dror Alishekevitz, Svetlana Gingis-Veltski, et al.
Scientific Reports|September 1, 2019
Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cellsMadeleine Benguigui, Iris S Weitz, Michael Timaner, et al.
Oncogene|January 16, 2023
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitorsAvital Vorontsova, Tim J Cooper, Jozafina Haj-Shomaly, et al.
Cancer Research|January 6, 2018
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating CellsMichael Timaner, Nitzan Letko-Khait, Ruslana Kotsofruk, et al.
Frontiers in Immunology|July 25, 2022
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant TumorsMadeleine Benguigui, Avital Vorontsova, Michael Timaner, et al.
Cancers|June 2, 2021
Metronomic Chemotherapy Modulates Clonal Interactions to Prevent Drug Resistance in Non-Small Cell Lung CancerMaryna Bondarenko, Marion Le Grand, Yuval Shaked, et al.
Oncotarget|September 9, 2015
Dequalinium blocks macrophage-induced metastasis following local radiationMichael Timaner, Rotem Bril, Orit Kaidar-Person, et al.
Journal for Immunotherapy of Cancer|June 18, 2021
IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cellsKsenia Magidey-Klein, Tim J Cooper, Ksenya Kveler, et al.
Pageof 4